Suppr超能文献

亨德拉病毒:马的诊断、疫苗接种及生物安全协议最新情况

Hendra Virus: An Update on Diagnosis, Vaccination, and Biosecurity Protocols for Horses.

作者信息

Wang Xueli, Wise Jessica C, Stewart Allison J

机构信息

School of Veterinary Science, The University of Queensland, Gatton Campus, Building 8114, Inner Ring Road, Gatton, Queensland 4343, Australia.

School of Veterinary Science, The University of Queensland, Gatton Campus, Building 8114, Inner Ring Road, Gatton, Queensland 4343, Australia.

出版信息

Vet Clin North Am Equine Pract. 2023 Apr;39(1):89-98. doi: 10.1016/j.cveq.2022.11.009. Epub 2023 Feb 1.

Abstract

Hendra virus (HeV) emerged as a zoonotic pathogen in the 1990s, causing low morbidity but high mortality in humans and horses. Pteropid bats are the natural reservoir of HeV and other important zoonotic viruses such as Nipah and Ebola viruses. Equivac HeV, manufactured by Zoetis (Parkville, Victoria, Australia), is the only commercially available vaccine for horses. There is no commercial vaccine for humans. The epidemiology, clinical features, pathology, diagnosis, management, and prevention of HeV will be reviewed.

摘要

亨德拉病毒(HeV)于20世纪90年代作为一种人畜共患病原体出现,在人类和马匹中发病率低但死亡率高。狐蝠是HeV以及其他重要人畜共患病病毒(如尼帕病毒和埃博拉病毒)的天然宿主。由硕腾公司(澳大利亚维多利亚州帕克维尔)生产的Equivac HeV是唯一可用于马匹的商业疫苗。目前尚无用于人类的商业疫苗。本文将对HeV的流行病学、临床特征、病理学、诊断、管理和预防进行综述。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验